Rosiglitazone inhibits the insulin-mediated increase in PAI-1 secretion in human abdominal subcutaneous adipocytes.

Alison Harte, Philip McTernan, CL McTernan, SA Smith, Anthony Barnett, Sudhesh Kumar

Research output: Contribution to journalArticle

40 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Rosiglitazone inhibits the insulin-mediated increase in PAI-1 secretion in human abdominal subcutaneous adipocytes.'. Together they form a unique fingerprint.

Medicine & Life Sciences